Form 4 filings across 5 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$29.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 10 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 1 business day late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured
The 55 most recent Form 4 transactions.
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 3,789 | — | — | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 3,789 | — | — | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 43,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 43,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 2.7M | $124.00 | $337M | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 2.7M | $124.00 | $337M | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS | 3,444 | $124.00 | $427.1K | -100.0% | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | UTENDR | 5,146 | $124.00 | $638.1K | -100.0% | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | UTENDR | 5,146 | $124.00 | $638.1K | -100.0% | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS | 650,000 | $124.00 | $80.6M | -100.0% | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS | 8.3M | $124.00 | $1B | -100.0% | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS | 8.3M | $124.00 | $1B | -100.0% | Open the original filing on SEC.gov |
| Jun 16 | NUVL | Nuvalent, Inc. | AGRANT | 3,444 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 464,550 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 464,550 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 246,732 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 246,732 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 143,650 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 143,650 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 166,070 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 166,070 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV | 407,132 | — | — | +76.3% | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV | 407,132 | — | — | +76.3% | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV | 260,992 | — | — | +95.9% | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV | 260,992 | — | — | +95.9% | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV | 149,238 | — | — | +121.3% | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV | 149,238 | — | — | +121.3% | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV | 122,990 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV | 122,990 | — | — | — | Open the original filing on SEC.gov |
| May 19 | LRMR | Larimar Therapeutics, Inc. | AGRANT◆ | 55,150 | — | — | — | Open the original filing on SEC.gov |
| Feb 27 | LRMR | Larimar Therapeutics, Inc. | PBUY | 2M | $5.00 | $10M | +47.5% | Open the original filing on SEC.gov |
| Feb 27 | LRMR | Larimar Therapeutics, Inc. | PBUY | 831,978 | $5.00 | $4.2M | +11.4% | Open the original filing on SEC.gov |
| Feb 27 | LRMR | Larimar Therapeutics, Inc. | PBUY | 1.1M | $5.00 | $5.4M | +11.4% | Open the original filing on SEC.gov |
| Feb 27 | LRMR | Larimar Therapeutics, Inc. | PBUY | 1.1M | $5.00 | $5.4M | +11.4% | Open the original filing on SEC.gov |
| Nov 24, 2025 | NUVL | Nuvalent, Inc. | SSELL | 371,287 | $95.45 | $35.4M | -4.3% | Open the original filing on SEC.gov |
| Nov 24, 2025 | NUVL | Nuvalent, Inc. | SSELL | 371,287 | $95.45 | $35.4M | -4.3% | Open the original filing on SEC.gov |
| Jul 31, 2025 | LRMR | Larimar Therapeutics, Inc. | PBUY | 2.6M | $3.20 | $8.3M | +55.1% | Open the original filing on SEC.gov |
| Jul 31, 2025 | LRMR | Larimar Therapeutics, Inc. | PBUY | 3.4M | $3.20 | $10.8M | +55.1% | Open the original filing on SEC.gov |
| Jul 31, 2025 | LRMR | Larimar Therapeutics, Inc. | PBUY | 3.4M | $3.20 | $10.8M | +55.1% | Open the original filing on SEC.gov |
| Jun 27, 2025 | SPRY | ARS Pharmaceuticals, Inc. | SSELL | 370,074 | $18.46 | $6.8M | -7.0% | Open the original filing on SEC.gov |
| Jun 27, 2025 | SPRY | ARS Pharmaceuticals, Inc. | SSELL | 370,075 | $18.46 | $6.8M | -7.0% | Open the original filing on SEC.gov |
| Jun 18, 2025 | NUVL | Nuvalent, Inc. | AGRANT◆ | 4,147 | — | — | — | Open the original filing on SEC.gov |
| Jun 18, 2025 | NUVL | Nuvalent, Inc. | AGRANT◆ | 4,147 | — | — | — | Open the original filing on SEC.gov |
| Jun 18, 2025 | NUVL | Nuvalent, Inc. | AGRANT | 2,647 | — | — | — | Open the original filing on SEC.gov |
| Jun 18, 2025 | NUVL | Nuvalent, Inc. | AGRANT | 2,647 | — | — | — | Open the original filing on SEC.gov |
| May 13, 2025 | LRMR | Larimar Therapeutics, Inc. | AGRANT◆ | 19,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 21, 2025 | PHGE | BiomX Inc. | AGRANT◆ | 1.6M | — | — | — | Open the original filing on SEC.gov |
| Apr 21, 2025 | PHGE | BiomX Inc. | AGRANT◆ | 1.6M | — | — | — | Open the original filing on SEC.gov |
| Apr 14, 2025 | PHGE | BiomX Inc. | AGRANT◆ | 17,600 | — | — | — | Open the original filing on SEC.gov |